Introduction {#Sec1}
============

Influenza viruses are the most common cause of respiratory infections, resulting in high morbidity and mortality (Taubenberger and Morens [@CR10]). Influenza is an infectious disease caused by influenza virus type A or B. The occurrence of influenza, whose viruses are characterized by great seasonal antigenic changeability, may vary in different districts of a country. In Poland, epidemiological surveillance of influenza was implemented in collaboration with primary care physicians and laboratories of 16 Voivodeship (province) Sanitary Epidemiological Station (VSES) as of the 2004/05 epidemic season. The information on influenza and influenza-like infections has been gathered in all districts by means of both Sentinel and non-Sentinel systems. Since the 2013/14 epidemic season, data consisting of the number of samples tested, suspected and confirmed cases of infection, hospitalizations, and deaths in each province are stratified into seven age-groups (Hallmann-Szelińska et al. [@CR6], [@CR7]; Bednarska et al. [@CR1]). These data are then further elaborated and randomly checked for correctness of viral identification in the National Influenza Center (NIC) at the National Institute of Public Health-National Institute of Health (NIPH-NIH [@CR9]). The NIC serves as a reference center for individual virological VSES laboratories of the country.

The aim of the present study was to determine the regional differences of influenza activity in Poland in the 2015/16 epidemic season. The savvy of such differences might be of help in setting apart resources for preventive and therapeutic actions to combat the epidemic.

Methods {#Sec2}
=======

Clinical Specimens {#Sec3}
------------------

The study was approved by an institutional Ethics Committee and it was conducted in accordance with the Declaration of Helsinki for Human Research. In the 2015/16 epidemic season over 8300 specimens were tested. The material consisted of nasal and throat swabs and bronchoalveolar lavage fluid (BALF). Clinical specimens were collected from week 40/2015 to week 34/2016 (October 1/2015 -- August 28/2016).

Extraction of Viral RNA {#Sec4}
-----------------------

Viral RNA was isolated using a Maxwell 16 Viral Total Nucleic Acid Purification Kit (Promega Corporation; Madison, WI) from 200 μL of clinical samples in phosphate-buffered saline (PBS) in accordance with the manufacturer's instructions for low elution volume cartridges. The RNA was eluted with 50 μL of RNase-free water.

Real-Time Quantitative Reverse Transcription Polymerase Chain Reaction (Q-RT-PCR) {#Sec5}
---------------------------------------------------------------------------------

The Q-RT-PCR was used for a molecular examination of the presence of influenza viral material. The analysis was carried out using a Light Thermocycler 2.0 System (Roche Diagnostics; Rotkreuz, Switzerland). The reaction proceeded in capillaries of 20 μL volume. Primers and probes necessary to carry out the reaction were obtained through the Influenza Reagent Resource (IRR) program from the US Center for Disease Control (CDC) The reaction mixture contained MgSO~4~, reaction buffer - bovine serum albumin (BSA), RNase free water, and a SuperScript^®^ III/platinum *Taq* mix (Invitrogen Life Technologies-Thermo Fisher Scientific; Carlsbad, CA), with the addition of 5 μL of the previously isolated RNA for each sample. The positive control constituted the RNA strains that were the following vaccine components for the 2015/16 epidemic season/2016: A/H1N1/pdm09 (A/California/7/2009), A/H3N2/Switzerland/9715293/2013, and B/Phuket/3073/2013. As for the negative, RNase-free water was used. Before the start of amplification, the RNA was rewritten to obtain cDNA, using the enzyme reverse transcriptase at 50 °C for 30 min. Then, samples were analyzed as follows: initialization at 95 °C for 2 min and 45 cycles of amplification consisting of denaturation at 95 °C for 15 s, annealing at 55 °C for 30 s, and elongation at 72 °C for 2 min.

Results {#Sec6}
=======

Influenza {#Sec7}
---------

In the 2015/2016 epidemic season in Poland over eight thousand five hundred specimens for influenza and influenza-like viruses were examined. The presence of influenza virus was found in over three thousand cases. The number of confirmed cases and share of various types of virus are presented in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Percentage distribution of influenza and influenza-like infections in the Polish provinces in the 2015/16 epidemic season. The province number, placed under each set of bars, corresponds to the numbered names of provinces provided in the tables

The majority of confirmations of influenza were found in the Pomeranian (72%), Masovian (62%), and Subcarpathian (55%) provinces. In other provinces, influenza was confirmed in less than half specimens investigated (Fig. [1](#Fig1){ref-type="fig"} and Table [1](#Tab1){ref-type="table"}).Table 1Confirmed influenza cases in the 2015/16 epidemic season in PolandProvinceSpecimens (n)Positive (%)1Podlaskie137212Kuyavia-Pomerania414373Pomerania97724Lubuskie243325Silesia815396Swietokrzyskie312387Lesser Poland1502388Lublin454459Lodz1544110Warmia--Masuria3862511Opole61812Greater Poland15152013Subcarpathia5715514West Pomerania9213515Masovia6816216Lower Silesia27940Total854237

We further found that the predominant subtype of influenza A virus in the 2015/16 season was A/H1N1/pdm09 that was detected in high percentage of influenza infection in several provinces, such as Pomerania (80%), Podlaskie (76%), Subcarpathia (74%), Lubuskie (71%), Silesia, and Warmia-Masuria (69%), with a smaller contribution from other provinces. In two provinces, Swietokrzyskie and Greater Poland, there was an equal frequency of type A and B viruses. Subtype A/H3N2/ accounted for one percent in the Kuyavian-Pomeranian and Masovian provinces. Apart from the two subtypes, there were unsubtyped cases of influenza infection (60%). These infections occurred most frequently in the province of Opole (Table [2](#Tab2){ref-type="table"}).Table 2Percentage distribution (%) of influenza virus infections in the Polish provinces in the 2015/16 epidemic seasonProvinceA/H1N1/ (%)A/H1N1/pdm09 (%)A/H3N2/ (%)A unsubtyped (%)B (%)1Podlaskie07603212Kuyavia-Pomerania052113343Pomerania08006144Lubuskie17100285Silesia06900316Swietokrzyskie23044517Lesser Poland035031348Lublin055024219Lodz0620251310Warmia--Masuria1690102011Opole000604012Greater Poland052024613Subcarpathia074017914West Pomerania221086915Masovia45111%2516Lower Silesia0670825

Type B virus predominated in West Pomerania (69% of infections) and also accounted for a substantial share of more than one third of the confirmed cases in Lesser Poland (Table [2](#Tab2){ref-type="table"}).

Influenza-Like Illness {#Sec8}
----------------------

Influenza-like infections (ILI) accounted for over 20% of all infections in the Opole and Greater Poland provinces. In other regions of the country these infections were rather sporadic (Fig. [1](#Fig1){ref-type="fig"}). The respiratory syncytial virus was the most common cause of ILI. Other viruses, such as human metapneumovirus, adenovirus, coronavirus 229E/NL63, parainfluenzavirus 1-3, coronavirus OC43, and rhinovirus A/B were identified in individual cases.

Discussion {#Sec9}
==========

In the 2015/16 epidemic season in Poland, over three thousand respiratory virus infections were confirmed. There were 3,864,731 cases and suspected cases of influenza and influenza-like illness, 15,312 hospitalizations, and 140 deaths (NIPH-NIH [@CR9]). Most cases and suspected cases were reported in the Pomeranian (765,296), Masovian (689,370), and Greater Poland (546,357) provinces as shown in Fig. [1](#Fig1){ref-type="fig"}. The highest incidence per 100,000 population was in Pomerania (4383.7) and Greater Poland (2086.2). The predominant subtype A/H1N1/pdm09 accounted for over 70% of confirmed cases of influenza infections. It should be noted that the WHO provides that each year from 330 million to 1.58 billion people worldwide suffer from influenza and influenza-like infections (WHO [@CR11]).

A high percentage of infection by subtype A/H1N1/pdm09 may stem from a low level of vaccination coverage in Poland amounting to about 3.6% of the population (Brydak [@CR4]). This subtype was recommended as a component of influenza vaccine in the 2015/16 epidemic season (WHO [@CR11]) and it also is going to be included into the 2016/17 vaccine (WHO [@CR12]). Influenza virus type B was the most frequent in the West Pomerianian and Swietokrzyskie provinces, accounting for more than half of the confirmed infections (Table [1](#Tab1){ref-type="table"}). A similar number of cases of influenza B and influenza-like infections was observed in the Opole and Greater Poland provinces, amounting to about 30% each. The majority of deaths occurred in the region of Silesia (33), in which the most frequently detected virus was influenza type A. There also were 25 deaths reported in Greater Poland, where virus type A (39%), B (32%), and viruses causing influenza-like illness (29%) were at a grossly comparable level. The WHO estimates that 1 million people die each year due to influenza infection (Brydak [@CR2]).

The present virological data indicate the predominance of infection with influenza virus type A in the eastern Polish provinces: Subcarpathian (91%), Lublin (80%), and Podlaskie (74%), lying near the border with Russia. These infection may be related to border trafficking between the two countries as type A virus was confirmed as predominant from week 3 of 2016 in Russia (Kimissarov et al. [@CR8]). However, predominance of type A virus in 2015/16 was also confirmed in Slovakia, Ukraine, Belarus, and Lithuania (Flu News Europe [@CR5]).

A decline in the number of confirmed cases of influenza virus subtype A/H3N2/, which accounted for only 1% in the Kuyavian-Pomerianian and Masovian provinces, was observed in 2015/16 compared with that in 2014/15 (Bednarska et al. [@CR1]); a situation similar to that also noted in Russia where this subtype caused only sporadic infections (Kimissarov et al. [@CR8]). In contrast, predominance of influenza virus type B was observed the West Pomerania that lies west of the provinces above mentioned near Germany where type B virus was found to predominate in the 2015/16 influenza season (Flu News Europe [@CR5]). Therefore, it seems that the regional differences in the type of influenza virus causing infections in a given season have in all probability to do with the epidemiological situation in neighboring countries.
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